{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-036112","form_type":"8-K","ticker":"INBS","cik":"0001725430","company_name":"INTELLIGENT BIO SOLUTIONS INC.","filed_at":"2026-08-05T12:55:18+00:00","discovered_at":"2026-08-05T13:00:11.347598+00:00","generated_at":"2026-08-05T13:00:23.889933+00:00","sec_items":["7.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Intelligent Bio Solutions completes usability study for FDA 510(k) submission for drug screening system","bullets":["Study confirms system can be effectively administered by operators with no specialist background.","Study conducted with CenExel Clinical Research; 15 operators participated.","On track to submit 510(k) package in H2 2026 for U.S. market clearance for opiate codeine detection.","Part of broader submission program including cut-off, method comparison, interference, and precision studies.","Targets entry into the multi-billion-dollar U.S. drug screening market."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-036112","json":"https://secwatch.observer/filing/0001493152-26-036112.json","markdown":"https://secwatch.observer/filing/0001493152-26-036112.md","text":"https://secwatch.observer/filing/0001493152-26-036112.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725430/000149315226036112/0001493152-26-036112-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725430/000149315226036112/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-05T13:00:23.889933+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}